PHILLIP ABSOLUTE 10 – Our top 10 picks for absolute returns
Source: Bloomberg, PSR
Phillip Absolute 10 performance assumes equal weightage to every stock in the portfolio. Any changes to Phillip portfolio is only conducted month end.
In our inaugural Phillip Absolute 10 Model portfolio, it was up 4.9% in January. It outperformed the STI by 1% point. Our portfolio underperformed this month, hurt by the performance of Geo Energy, Chip Eng Seng and Micro-Mechanics. Only DBS managed to generate positive gains for us in February. Our portfolio for March will exit DBS and replace it with OCBC.
Below are some quick updates on some of the Absolute 10 portfolio:
OCBC: We will be removing DBS and replacing with OCBC. Due to the outperformance in DBS, we believe OCBC will be a better proxy to banking sector. OCBC will enjoy the upside in interest rates through the insurance arm and leveraged on the rebound in credit cycle in both Singapore and Hong Kong.
Geo Energy: Share price has suffered due to weak production in 4Q17 and regulatory noise out of Indonesia. We still like the stock for the attractive valuations, growth in production and healthy coal prices.
Chip Eng Seng: We maintain our Accumulate call on CES with unchanged target price as we see strong revenue visibility for FY18/19 with an estimated $210mn of unbooked development profits from High Park and Grandeur Park Residences. The improving hospitality and construction segments will continue to support recurring income. The Group’s recent announcement to diversify into the Education sector remains a mid-long term goal. We will update accordingly, when there is more clarity. Dividend yield, which we expect to be maintained, is at an attractive >4% level, and target price is at a steep 40% discount to RNAV.
Micro-Mechanics: Whilst the results reflected some weakening in momentum, we still are upbeat on the company. The attractive investment merits of Micro-Mechanics have not changed: ROE of >30%, ~60% GP margins, net cash $22mn balance sheet and 3% dividend yield.
Dairy Farm: Most of its segments and its two key associates returned strong performances, while we saw persistent weakness in SE Asia. We like Dairy Farm on its well-established regional presence and solid financial positions. Near-term catalysts include recovery in SE Asia consumer sentiment as well as higher Chinese tourist arrivals to Hong Kong and Macau; increasing online and offline network; and margin gains via better sales mix and economies of scale.
Banyan Tree: We maintain our Accumulate call on BTH with unchanged target price as FY17 results continue to show improved operating performance across its key markets, with the exception of Maldives. RevPAR for Thailand, which accounts for close to 60% of Group revenue by our estimates, jumped c.13% on average for FY17. We expect this strength to continue, especially with the low base in 1H17, after the King is passing. Forward indicators also reflect a more favourable outlook across all business segments as hotel forward bookings jump 15% YoY for 1Q18. The Group’s general offer for Laguna Resorts & Hotel reflects a potential greater sense of urgency to monetize/ develop the existing land bank, which could be further catalysts to share price.
For the full Singapore Monthly for March 2018 report.
Important Information
This report is prepared and/or distributed by Phillip Securities Research Pte Ltd ("Phillip Securities Research"), which is a holder of a financial adviser’s licence under the Financial Advisers Act, Chapter 110 in Singapore.
By receiving or reading this report, you agree to be bound by the terms and limitations set out below. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.
The information and any analysis, forecasts, projections, expectations and opinions (collectively, the “Research”) contained in this report has been obtained from public sources which Phillip Securities Research believes to be reliable. However, Phillip Securities Research does not make any representation or warranty, express or implied that such information or Research is accurate, complete or appropriate or should be relied upon as such. Any such information or Research contained in this report is subject to change, and Phillip Securities Research shall not have any responsibility to maintain or update the information or Research made available or to supply any corrections, updates or releases in connection therewith.
Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this report are as of the date indicated and are subject to change at any time without prior notice. Past performance of any product referred to in this report is not indicative of future results.
This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This report should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own independent verification and exercise of judgment. The fact that this report has been made available constitutes neither a recommendation to enter into a particular transaction, nor a representation that any product described in this report is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may be described in this report involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made, unless all such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks.
Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any decision to purchase any product mentioned in this report should take into account existing public information, including any registered prospectus in respect of such product.
Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may provide an array of financial services to a large number of corporations in Singapore and worldwide, including but not limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting activities), brokerage or securities trading activities. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have participated in or invested in transactions with the issuer(s) of the securities mentioned in this report, and may have performed services for or solicited business from such issuers. Additionally, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have provided advice or investment services to such companies and investments or related investments, as may be mentioned in this report.
Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report may, from time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price or income return of the investment.
To the extent permitted by law, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may at any time engage in any of the above activities as set out above or otherwise hold an interest, whether material or not, in respect of companies and investments or related investments, which may be mentioned in this report. Accordingly, information may be available to Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, which is not reflected in this report, and Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following its publication. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the issuance of this report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of this report.
The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities Research to any registration or licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction.
This report is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. The products mentioned in this report may not be suitable for all investors and a person receiving or reading this report should seek advice from a professional and financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, before making a commitment to invest in any of such products.
This report is not intended for distribution, publication to or use by any person in any jurisdiction outside of Singapore or any other jurisdiction as Phillip Securities Research may determine in its absolute discretion.
IMPORTANT DISCLOSURES FOR INCLUDED RESEARCH ANALYSES OR REPORTS OF FOREIGN RESEARCH HOUSE
Where the report contains research analyses or reports from a foreign research house, please note:
